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Abstract Similar to melanocyte stimulating hormone (K-
MSH), its potent and long-acting analogue, [Nle4, D-Phe7]K-
MSH, when labeled with the paramagnetic amino acid probe
2,2,6,6-tetramethylpiperidine-N-oxyl-4-amino-4-carboxylic acid
(Toac), maintains its full biological potency, thus validating any
comparative structural investigations between the two labeled
peptides. Correlation times, calculated from the electron
paramagnetic resonance signal of Toac bound to the peptides,
and Toac^Trp distances, estimated from the Toac fluorescence
quenching of the Trp residue present in the peptides, indicate a
more rigid and folded structure for the potent analogue as
compared to the hormone, in aqueous medium. ß 2001 Pub-
lished by Elsevier Science B.V. on behalf of the Federation of
European Biochemical Societies.
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1. Introduction
In most vertebrates, the linear tridecapeptide K-melanocyte
stimulating hormone (K-MSH; acetyl-SYSMEHFRWGKPV-
amide) is known as the most relevant physiological hormone
regulating skin darkening [1]. This peptide is also involved in
a variety of other physiological and neurological processes,
such as fetal growth, thermoregulation, food intake, learning,
memory and attention [2]. The minimal sequence required to
stimulate melanocytes was determined to be the core 6-9 frag-
ment, generally referred to as the primary active site or ‘mes-
sage sequence’ [3], due to its conservation in several species.
Among the several K-MSH analogues, [Nle4, D-Phe7]K-MSH
(hereafter referred to as NDP-MSH) has been identi¢ed as
very potent and long-acting analogue in various vertebrate
species [4,5]. Due to its high activity and enzymatic resistance,
this analogue has been used in the characterization of mela-
nocortin receptors, mainly by radioligand binding analysis
[5,6].
Although the important question about the hormone struc-
ture^activity relationship has been largely addressed in the
melanotropic peptides literature, there is not a consensus
about the conformations acquired by both K-MSH and
NDP-MSH, either in solution or during the membrane^recep-
tor binding. Several studies have indicated that the peptides
assume a folded conformation in aqueous medium (a L-struc-
ture or a hairpin loop), comprising the critical 6-9 fragment,
and it was postulated that the increased potency of the NDP-
MSH derivative was due to a reverse turn-type structure sta-
bilized by the D-Phe7 substitution [7^9]. Otherwise, there are
investigations pointing to a rather £exible backbone for
K-MSH in solution, whereas the presence of the D-Phe7 resi-
due favors a more folded structure for the NDP-MSH ana-
logue [10^12]. It is noteworthy that in the presence of either
anionic sodium dodecylsulfate micelles or dimyristoyl phos-
phatidylglycerol vesicles, a small percentage of the proposed
biological relevant structure (a L-like conformation) could be
observed in the circular dichroism spectra of both peptides
[11]. That result should be regarded in the light of the possible
catalytic role of the membrane bilayer phase, inducing a par-
ticular peptide conformation appropriate for its interaction
with the receptor [13].
To initiate an alternative conformational approach for me-
lanotropic peptides studies, we have recently reported [14] the
synthesis of a paramagnetic K-MSH analogue labeled with
Toac, an amino acid-type spin probe (2,2,6,6-tetramethylpi-
peridine-N-oxyl-4-amino-4-carboxylic acid) earlier introduced
[15,16] in the peptide chemistry ¢eld. As emphasized in those
works, due to the special rigidity of its covalent binding to the
peptide molecule, the Toac spin label is highly sensitive to the
peptide backbone conformation and dynamics. Despite the
insertion of this non-natural probe in its structure, the syn-
thesized Ac-Toac0-K-MSH analogue maintained its original
potency in the frog Rana catesbeiana skin bioassay thus be-
coming [14] the ¢rst example of fully active spin-labeled pep-
tide hormone.
By pursuing the synthesis of alternative fully active para-
magnetic melanotropic derivatives for further comparative
physiological studies, the present work describes the successful
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Toac-labeling of the more potent and long-acting NDP-MSH
derivative. The ¢ndings here detailed for the synthesized Ac-
Toac0-NDP-MSH analogue demonstrate that the NDP-MSH
original activity was entirely maintained after this structural
modi¢cation, thus validating any further conformational stud-
ies of this class of peptides. In addition to the electron para-
magnetic resonance (EPR) analysis of the Toac signal of the
labeled melanotropic peptides, the presence of the naturally
£uorescent Trp residue in their core sequences has also al-
lowed structural comparisons between labeled K-MSH and
NDP-MSH analogues via the Trp £uorescence quenching
due to energy transfer to the Toac molecule.
2. Materials and methods
2.1. Peptide synthesis
The NDP-MSH and Ac-Toac0-NDP-MSH analogues were synthe-
sized in the same manner as already detailed for the native K-MSH
and its Ac-Toac0-K-MSH derivative [14]. The base labile 9-(£uorenyl-
methyloxycarbonyl) group (Fmoc) was used for temporary protection
of the Toac K-amine group which allows its insertion at any position
in the peptide sequence without the danger in decomposing its nitrox-
ide function during the synthesis cycle. After HF cleavage, the ex-
tracted spin-labeled analogue was submitted to alkaline treatment for
complete reversion (monitored by analytical high performance liquid
chromatography (HPLC)) of the N^O protonation that occurs during
this anhydrous acid treatment. After puri¢cation in preparative HPLC
(C18 (octadecyl) column) using aqueous 0.02 M ammonium acetate
(pH 5.0) and 60% acetonitrile solutions as solvents A and B, the
puri¢ed NDP-MSH and Ac-Toac0-NDP-MSH peptides were charac-
terized by analytical HPLC, mass spectrometry and amino acid anal-
ysis.
2.2. Biological assay [17,18]
The thigh and dorsal skin of the frog, R. catesbeiana, was excised,
cut in square (2U2 cm) pieces, which were placed between two PVC
rings and kept for 1 h in Ringer’s solution. After this period, the
melanin granules were aggregated in the perinuclear region of the
melanocytes, which assumed a punctate state, leading to skin light-
ening. Upon addition of Ac-NDP-MSH or Toac0-NDP-MSH to the
medium, the pigment disperses out into the dendritic processes of the
cell, resulting in skin darkening. The changes in skin color (decrease in
skin re£ectance) were monitored with a Photovolt re£ectometer and
expressed as percent change of the initial value. Dose^response curves
and the EC50s (the concentration eliciting 50% of the maximal dark-
ening, con¢dence interval (CI) of 95%) were determined for the pep-
tides. The data were compared employing the SNK test (P9 0.05).
2.3. Sample preparation
For the spectroscopic measurements, stock solutions of the peptides
(1033 M) were prepared in water and diluted to the ¢nal desired
concentrations. The values of pH were adjusted with HCl or NaOH.
2.4. EPR spectroscopy
EPR measurements were performed at 25‡C with a Bruker EMX
spectrometer. A ¢eld-modulation amplitude of 0.5 G and microwave
power of 5 mW were used. The temperature was controlled to about
0.2‡C with a Bruker BVT-2000 variable temperature device. The spec-
tral parameters were found by ¢tting each line to a Gaussian^Lor-
entzian sum function taking advantage of the fact that the sum func-
tion is an accurate representation of a Voigt function [19]. The
corrected B and C parameters were calculated as described by Bales
[19], as a function of the three line heights, making the corrections for
the contribution of non-resolved hyper¢ne splittings. Rotational cor-
relation times were calculated with both parameters, and called dB and
dC, using the principal components of the g and hyper¢ne tensors of
doxyl-propane, and 3300 G for the magnetic ¢eld [20]. Considering
that those two correlation times should be identical for rapid, iso-
tropic movement, and due to the di⁄culty in postulating a preferential
rotational axis, the movement asymmetry will be estimated by the
ratio between dC and dB. The hyper¢ne splitting, ao, was taken to
be one-half the di¡erence in the resonance ¢elds of the high- and
low-¢eld lines (¢t by the computer program).
2.5. Optical and £uorescence spectroscopies
Optical absorption measurements were performed with a HP 8452
A diode array spectrophotometer. For steady state £uorescence ex-
periments a Fluorolog 3 Jobin Yvon-Spex spectrometer was used,
with excitation and emission slits of 1 mm or 2 mm, depending on
the £uorescence intensity of the sample. The excitation wavelength
was set to 295 nm and the quantum yields were estimated using the
Trp value 0.14 as a reference. Time-resolved experiments were per-
formed using an apparatus based on the time-correlated single photon
counting method. The excitation source was a Tsunami 3950 Spectra
Physics titanium^sapphire laser, pumped by a 2060 Spectra Physics
argon laser. The repetition rate of the 5 ps pulses was set to 400 kHz
with the pulse picker 3980 Spectra Physics. The laser was tuned to
give an output at 897 nm, and a third harmonic generator BBO
crystal (GWN-23PL Spectra Physics) gave the 297 nm excitation pulse
that was directed to an Edinburgh FL900 spectrometer. The emission
wavelength was selected by a monochromator, and emitted photons
were detected at right angle from excitation by a refrigerated Hama-
matsu R3809U microchannel plate photomultiplier. The FWHM (full
width at half maximum) of the instrument response function was
typically 45 ps and the time resolution 12 ps per channel. A software
provided by the Edinburgh Instruments was used to analyze the decay
curves and the adequacy of the ¢tting was judged by the inspection of
the weighted residual plots and by the analysis of statistical parame-
ters such as reduced chi-square.
3. Results and discussion
The in vitro frog (R. catesbeiana) skin bioassay was per-
formed as previously described [17,18]. NDP-MSH from Sig-
ma, NDP-MSH and Ac-Toac0-NDP-MSH (this paper) are
full agonists on the frog melanocyte, promoting a dose-depen-
dent skin darkening (Fig. 1), and are about ¢ve to eight times
more potent than K-MSH in this bioassay (1.96U10310 M
[14]). The EC50s and the CIs of 95% were 2.4U10311 M
(0.38^8.57), 3.8U10311 M (0.59^13.56) and 3.7U10311 M
(0.58^13.21), respectively, and were not statistically di¡erent.
After the removal of these compounds, and several rinses in
Ringer’s solution, the reversal of the maximal responses was
not achieved, at least until 90 min (data not shown). It had
Table 1
EPR parameters for free Toac and Toac bound to the peptides: nitrogen isotropic hyper¢ne splitting, ao, and rotational correlation times, dB
and dC
System ao (G) dB (ns) dC (ns) dC/dB
Toac (pH 5.0) 16.330 0.034 0.036 1.06
pH 3.0 Ac-Toac0-K-MSH 16.238 0.314 0.370 1.18
Ac-Toac0-NDP-MSH 16.231 0.333 0.408 1.22
pH 5.0 Ac-Toac0-K-MSH 16.249 0.306 0.359 1.17
Ac-Toac0-NDP-MSH 16.241 0.321 0.391 1.22
pH 9.0 Ac-Toac0-K-MSH 16.252 0.301 0.353 1.17
Ac-Toac0-NDP-MSH 16.242 0.335 0.407 1.22
The estimated errors in the values of ao and dB or dC are 0.005 G and 0.005 ns, respectively.
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already been demonstrated that NDP-MSH is a potent and
long-acting agonist [4], and these properties were not changed
with the insertion of the spin label, Toac.
In aqueous solution, the paramagnetic Ac-Toac0-NDP-
MSH analogue displays an EPR spectrum similar to that
obtained with Ac-Toac0-K-MSH already reported [14]. The
parameters yielded by the EPR spectra of the two Toac-
bound peptides at di¡erent pH values are comparatively sum-
marized in Table 1. The EPR parameters (rotational correla-
tion times, dB and dC, and nitrogen isotropic hyper¢ne split-
ting, a0) are also compared to those of the free Toac molecule.
Considering that the free and the peptide-bound Toac EPR
spectra are typical of the motional narrowing region (between
10311 and 1039 s), the dB and dC values were calculated ac-
cording to Schreier et al. [20] using the corrections for non-
resolved hyper¢ne splittings proposed by Bales [19] (see Sec-
tion 2). As expected, the d values of both Toac-bound mela-
notropic peptides are one order of magnitude higher than
those of the free Toac molecule in solution, indicating that
the Toac peptide EPR spectrum re£ects the mobility of the
peptide backbone. This is in close accordance with data al-
ready reported for other small paramagnetic labeled active
peptides [14^16]. Moreover, considering that the ratio between
the two correlation times, dC/dB, can be used as an estimation
of the anisotropy of the spin-labeled systems [20], it is evident
that the binding to the peptides also turns the Toac movement
less isotropic (higher dC/dB ratio). It is interesting to note that
the correlation times are slightly higher for the Toac-contain-
ing NDP-MSH as compared to Ac-Toac0-K-MSH: dC values
are around 10%, 9% and 15% higher at pH 3, 5 and 9, re-
spectively. Besides displaying a slower rate of movement, the
former peptide also shows a more anisotropic rotation than
when bound to the latter ((dC/dB) = 1.22 and 1.17, respec-
tively), at the three pH values. Those results suggest that
the two peptides are characterized by di¡erent conformers.
The analysis of Toac nitrogen isotropic hyper¢ne splitting
(ao) values, which are sensitive to the polarity of the nitroxide
group micro-environment [21], also reveals a signi¢cant di¡er-
ence between the free and the peptide-bound spin label: in the
EPR spectra of the Toac-bound peptide, ao is 0.08^0.10 G
lower than that of the free paramagnetic molecule. That dif-
ference could be attributed to a less polar environment neigh-
boring the Toac nitroxide function, when inserted in the pep-
tide structure, and/or to a di¡erentiated unpaired electron
distribution over the N-O moiety of the spin probe, when in
the free or peptide-bound states. Otherwise, the ao values of
the Ac-Toac0-K-MSH are somehow higher than those of Ac-
Toac0-NDP-MSH, in all pH values. Considering that the co-
valent binding of Toac in the two peptides is identical, that
di¡erence could only be assigned to slightly di¡erent environ-
ments experienced by the paramagnetic molecule in the two
peptides. Taking together, the higher correlation times, the
higher anisotropy of movement, and the lower hyper¢ne
splitting indicate a slightly more folded structure for the
Toac-labeled potent analogue as compared to Ac-Toac0-K-
MSH.
Optical absorption spectra of Toac, K-MSH and Ac-Toac0-
K-MSH in aqueous solution, pH 7.0, are illustrated in Fig. 2.
Fig. 1. Dose^response curves to Ac-Toac0-NDP-MSH (R) as com-
pared to NDP-MSH (E, from Sigma; b, this paper) in the frog R.
catesbeiana skin bioassay. Each point represents the mean (n = 8)
þ S.E.M. darkening response at the concentration noted.
Fig. 2. Optical absorption spectra (optical path length 1.0 cm) of
K-MSH (a), Toac (b) and Ac-Toac0-K-MSH (c), and the £uores-
cence emission spectra of Ac-Toac0-K-MSH excited at 295 nm (d).
Peptides and Toac concentration 2.5U1035 M, in aqueous solution,
pH 7.0, 22‡C.
Table 2
Mean lifetime of Trp £uorescence decay, Gdf, and estimated Trp^
Toac distances in Toac-bound peptides, r
System Gdf (ns) r (Aî )
pH 3.0 K-MSH 1.95
Ac-Toac0-K-MSH 1.89 16.7
NDP-MSH 2.13
Ac-Toac0-NDP-MSH 1.75 12.1
pH 5.0 K-MSH 2.14
Ac-Toac0-K-MSH 2.03 15.3
NDP-MSH 2.30
Ac-Toac0-NDP-MSH 1.95 12.6
pH 9.0 K-MSH 2.62
Ac-Toac0-K-MSH 2.32 13.1
NDP-MSH 2.70
Ac-Toac0-NDP-MSH 2.17 12.1
The estimated error in the values of Gdf is 0.05 ns.
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In the near-UV region, around 280 nm (extinction coe⁄cient
W5.7U103 M31 cm31), the spectrum of the labeled peptide is
dominated by the electronic transitions characteristic of the
Trp residue, superimposed to a small contribution from the
Toac molecule. The Ac-Toac0-K-MSH also presents a very
weak absorption band centered around 410 nm, with an ex-
tinction coe⁄cient about 20 M31 cm31, as observed recently
[22] in Toac-bound peptides (not evident in Fig. 2, due to the
scale used). The same features are present in the spectrum of
the analogue Ac-Toac0-NDP-MSH (data not shown). Pure
Toac samples, excited at 295 nm, do not show any £uores-
cence emission. However, under excitation at that wavelength,
both labeled and unlabeled peptides present an emission band
centered around 355 nm, typical of Trp in aqueous environ-
ment (Fig. 1d). The values of the quantum yield of K-MSH
and NDP-MSH are about 0.090, comparable to previous re-
ports for the peptides [23]. Compared to non-labeled peptides,
the £uorescence intensity of Trp in the Toac-bound peptides
decreases, due to the quenching by the Toac group. In acidic
pH values the quantum yields of unbound and Toac-bound
peptides decrease with respect to the values at higher pH.
The excited state decay of all the compounds, labeled or
not, was found to be heterogeneous, as observed before for
the non-labeled peptides in neutral pH [23], and could be
properly ¢t with three lifetime components. The K-MSH
and NDP-MSH lifetime values for the high pH samples
were also comparable to those previously reported for the
peptides in bu¡er, pH 7.4. However, the Toac-labeled pep-
tides presented faster £uorescence decay (Fig. 3), compatible
with Trp £uorescence quenching by the spin label. The de-
crease in lifetime can be examined by calculating a mean life-
time Gdf for the decay, according to Gdf=gaidi2/gaidi, where di
and ai are the lifetime and the pre-exponential factor of the
i-th component, respectively. As observed in Table 2, lifetimes
of Toac-labeled peptides are systematically lower than those
of original peptides, independent of the solution pH value.
Mechanisms like charge transfer or collisional quenching
can contribute to the decrease of Trp £uorescence, and pro-
cesses requiring close proximity between the £uorophore and
nitroxide spin labels were assumed, for example, in the paral-
lax method employed to estimate the penetration depth of
melanotropins into the lipid bilayer of phospholipid vesicles
[24]. In the present case, as mentioned, the Toac peptides
present a very weak absorption band centered around
410 nm, overlapping the red tail of the Trp emission band,
allowing for £uorescence resonant energy transfer between the
side chain residue as donor and the spin probe as acceptor.
The Trp residue and the Toac group are far apart in the
peptide chain and the Fo«rster model was recently applied to
the study of the Toac-labeled peptides [22], and a Fo«rster
distance (Ro) of 9.3 Aî was calculated for the pair Trp^Toac.
Likewise, an estimation of the intramolecular Toac^Trp dis-
tances in the labeled melanotropins can be done, based on the
calculated mean lifetimes (Table 2). A donor^acceptor dis-
tance, r = Ro(1/E31)1=6, can be estimated from the e⁄ciency
of energy transfer, given by E = 13Gddaf/Gddf, where Gddaf and
Gddf are the mean lifetimes for the Toac-labeled and unlabeled
peptides, respectively, and using the Ro value calculated by
Pispisa et al. [22]. The estimated Toac^Trp distances given in
Table 2 were obtained under the assumption of fast move-
ment for donor and acceptor during the £uorescence lifetime.
As usually reported in the literature, donor^acceptor distances
are estimated within 20% error.
Our results demonstrate that, in all pH values, the Toac^
Trp distance is shorter in NDP-MSH, as compared to the
native peptide K-MSH. That ¢nding taken together with the
results from EPR spectroscopy as discussed above indicate a
more compact conformation for the potent analogue and ¢t
with the proposed turn in the NDP-MSH conformation [10^
12]. It should also be noted that the analogue conformation
does not seem to be dependent on the sample pH value,
whereas the Toac^Trp distance in K-MSH increases when
the pH decreases. Changes in the pH of the medium a¡ect
the protonation state of several side chain groups in the pep-
tides. Therefore, the consequences of those modi¢cations on
the conformation of the peptides could be evaluated from a
detailed study of EPR and £uorescence parameters of labeled
and non-labeled melanotropins as a function of the medium
pH value. We stress that the Toac^Trp distances presented
here are estimates of mean distances. More detailed informa-
tion about the conformation of the peptides will depend, for
example, on the analysis of the decay associated spectra, ef-
fects of the protonable groups, and analysis of resonant en-
ergy transfer in the framework of donor^acceptor distance
distribution models [25].
The Toac-labeling approach has been considered unique
and with great potential for application in a variety of bio-
chemical applications [26]. In this context, the relevance of the
present work refers to the introduction of a second fully active
Toac-labeled peptide hormone in the literature and its useful-
ness for structural investigation of melanotropic peptides, in
aqueous solution. Otherwise, when membrane-mimetic sys-
tems are taken into account, it is already known that this
class of peptides strongly interacts with anionic micelles and
vesicles, partially penetrating their hydrophobic core [11,27].
We can therefore envisage that, as an expected extension of
the present work, conformational changes upon insertion of
Toac-containing K-MSH and/or NDP-MSH peptides into the
lipid phase could be deeper investigated by simultaneous anal-
ysis of the £uorescence properties of Trp residue and the para-
magnetic properties of Toac, possibly inserted in di¡erent po-
sitions of the melanotropic peptide sequence.
Fig. 3. Fluorescence decay of K-MSH (a), and Ac-Toac0-K-MSH (b)
in aqueous solution, pH 7.0. Concentration 2.5U1035 M, 22‡C. The
instrument response function at 297 nm excitation is also shown (c).
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